The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Taking a long time to negotiate a price. And amazed by the plebs on here who think this share has to be suspended because of an offer, or lack of it. Obviously never owned any shares before.
Glad to see you all think everything's going to be fine, I'll be happy to see my money double here having invested 5 months ago, and I used to have shares in desire and med oil and gas, not that you lot would have a clue who they were.
You muppet, how do you think these cases work, you lose you pay the other parties legal fees, twat. You read up the Churchill mining verdict, 6 million pounds had to be secured against Indonesia's legal fees.
Think I'd prefer navitas sign off next week so we hit 20p and if we lose case it will only retrace to 10p. If we lose like Churchill mining did then we will be paying Italys legal costs, and that will be millions.
Breakeven has moved up from 40kt for sure, more sales staff, also they didnt give out directors bonuses last year because of share price performance, so I'm expecting a modest profit for 2021, and hoping we can get to 200kt sales in 2022, otherwise nowt all for shareholders.